Thomas W. Ku

1.9k total citations
33 papers, 1.1k citations indexed

About

Thomas W. Ku is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Thomas W. Ku has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Thomas W. Ku's work include Chemical Synthesis and Analysis (8 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Thomas W. Ku is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Thomas W. Ku collaborates with scholars based in United States, United Kingdom and Switzerland. Thomas W. Ku's co-authors include Peter Smith‐Jones, Diane S. Abou, William E. Bondinell, Fadia E. Ali, John G. Gleason, Steven M. Larson, Raul R. Calvo, Ashok K. Sharma, Daniel Swern and James S. Frazee and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas W. Ku

32 papers receiving 1.1k citations

Peers

Thomas W. Ku
Daniel E. Levy United States
John Wityak United States
Bruce E. Tomczuk United States
Diane A. Trainor United States
Wang‐Qing Liu France
Marie‐Claude Viaud‐Massuard France
Karl F. Erhard United States
Laurie Churchill United States
Philip G. Kasprzyk United States
Gary L. Olson United States
Daniel E. Levy United States
Thomas W. Ku
Citations per year, relative to Thomas W. Ku Thomas W. Ku (= 1×) peers Daniel E. Levy

Countries citing papers authored by Thomas W. Ku

Since Specialization
Citations

This map shows the geographic impact of Thomas W. Ku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas W. Ku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas W. Ku more than expected).

Fields of papers citing papers by Thomas W. Ku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas W. Ku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas W. Ku. The network helps show where Thomas W. Ku may publish in the future.

Co-authorship network of co-authors of Thomas W. Ku

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas W. Ku. A scholar is included among the top collaborators of Thomas W. Ku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas W. Ku. Thomas W. Ku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stelter, Lars, Michael J. Evans, Achim A. Jungbluth, et al.. (2012). Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest 18F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma. Journal of Nuclear Medicine. 53(2). 281–286. 14 indexed citations
2.
Abou, Diane S., Thomas W. Ku, & Peter Smith‐Jones. (2011). In vivo biodistribution and accumulation of 89Zr in mice. Nuclear Medicine and Biology. 38(5). 675–681. 234 indexed citations
3.
Zhang, Hanwen, Maxim A. Moroz, Inna Serganova, et al.. (2010). Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC. Journal of Nuclear Medicine. 52(1). 123–131. 59 indexed citations
4.
Carlin, Sean, et al.. (2010). Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts. PLoS ONE. 5(5). e10857–e10857. 47 indexed citations
5.
Burton, George, Thomas W. Ku, Thomas J. Carr, et al.. (2007). Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity. Bioorganic & Medicinal Chemistry Letters. 17(7). 1930–1933. 34 indexed citations
6.
Burton, George, Thomas W. Ku, Thomas J. Carr, et al.. (2005). Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture. Bioorganic & Medicinal Chemistry Letters. 15(6). 1553–1556. 58 indexed citations
7.
Keenan, Richard M., William H. Miller, M. Amparo Lago, et al.. (1998). Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonists. Bioorganic & Medicinal Chemistry Letters. 8(22). 3165–3170. 18 indexed citations
8.
Wong, Angela, Shing Mei Hwang, Kyung Johanson, et al.. (1998). Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to Purified Integrin αIIbβ3: Evidence for a Common Binding Site for Cyclic Arginyl-Glycinyl-Aspartic Acid Peptides and Nonpeptides. Journal of Pharmacology and Experimental Therapeutics. 285(1). 228–235. 3 indexed citations
9.
Ku, Thomas W., William H. Miller, William E. Bondinell, et al.. (1995). Potent non-peptide fibrinogen receptor antagonists which present an alternative pharmacophore. Journal of Medicinal Chemistry. 38(1). 9–12. 20 indexed citations
10.
Miller, William H., Thomas W. Ku, Fadia E. Ali, et al.. (1995). Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist. Tetrahedron Letters. 36(52). 9433–9436. 39 indexed citations
11.
Ali, Fadia E., Donald B. Bennett, Raul R. Calvo, et al.. (1994). Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation. Journal of Medicinal Chemistry. 37(6). 769–780. 35 indexed citations
12.
Ku, Thomas W., Mary E. McCarthy, Barry M. Weichman, & John G. Gleason. (1985). Synthesis and LTD4 antagonist activity of 2-norleukotriene analogs. Journal of Medicinal Chemistry. 28(12). 1847–1853. 21 indexed citations
13.
Bondinell, William E., James S. Frazee, Eleanor Garvey, et al.. (1985). ChemInform Abstract: ORALLY ACTIVE AND POTENT INHIBITORS OF Γ‐AMINOBUTYRIC ACID UPTAKE. Chemischer Informationsdienst. 16(34). 35 indexed citations
14.
Perchonock, Carl D., Irene N. Uzinskas, Thomas W. Ku, et al.. (1985). Synthesis and LTD4-antagonist activity of desamino-2-nor-leukotriene analogs. Prostaglandins. 29(1). 75–81. 7 indexed citations
15.
Weichman, Barry M., Martin A. Wasserman, D. A. Holden, et al.. (1983). Antagonism of the pulmonary effects of the peptidoleukotrienes by a leukotriene D4 analog.. Journal of Pharmacology and Experimental Therapeutics. 227(3). 700–705. 18 indexed citations
16.
Ku, Thomas W., et al.. (1982). New synthesis of some arylthio-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines. The Journal of Organic Chemistry. 47(20). 3862–3865.
17.
Ku, Thomas W. & Daniel Swern. (1979). IMINOSULFURANES FROM BIOLOGICALLY ACTIVE SULFONAMIDES AND RELATED COMPOUNDS. Phosphorous and Sulfur and the Related Elements. 7(2). 195–201. 1 indexed citations
18.
19.
Sharma, Ashok K., et al.. (1975). ChemInform Abstract: DIMETHYL SULFOXIDE‐TRIFLUOROACETIC ANHYDRIDE, A NEW AND EFFICIENT REAGENT FOR THE PREPARATION OF IMINOSULFURANES. Chemischer Informationsdienst. 6(52). 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel E. Levy Breakdown of academic impact, for papers by John Wityak Breakdown of academic impact, for papers by Bruce E. Tomczuk Breakdown of academic impact, for papers by Diane A. Trainor Breakdown of academic impact, for papers by Wang‐Qing Liu Breakdown of academic impact, for papers by Marie‐Claude Viaud‐Massuard Breakdown of academic impact, for papers by Karl F. Erhard Breakdown of academic impact, for papers by Laurie Churchill Breakdown of academic impact, for papers by Philip G. Kasprzyk Breakdown of academic impact, for papers by Gary L. Olson
Rankless by CCL
2026